Group 1 - Picard Medical Inc announced its initial public offering (IPO) of 4,250,000 shares at a price of $4.00 per share, aiming to raise approximately $17 million before underwriting discounts and expenses [2] - Picard is the only supplier of implantable total artificial hearts certified by both the FDA and Health Canada, with over 2,100 implant surgeries completed across 27 countries [2] - The company's common stock has been approved for listing on the New York Stock Exchange under the ticker symbol "PMI" [2] Group 2 - The funds raised from the IPO will be allocated to five main areas: market expansion, research and development, sales and distribution capabilities, debt repayment, and general corporate purposes [3] - Picard plans to establish a joint venture in China named SynCardia Medical (Beijing), Inc as part of its market expansion strategy [3] - The company aims to develop a new fully implanted total artificial heart called Emperor and a next-generation portable drive system as part of its R&D efforts [3]